
How generative AI is rewriting the rulebook for antibody drug discovery
Dr Kerstin Papenfuss, Deep Science Ventures, and Ben Holland, Antiverse, discuss how generative AI is helping advance antibody discovery. The therapeutic antibody, once 'the next big thing,' has matured into a cornerstone of modern medicine, standing alongside small molecules as a staple of drug development. Yet, while artificial intelligence (AI) has dramatically… Read More


